Nonmucinous Cystic Lesions of the Pancreas

Arch Pathol Lab Med. 2022 Mar 1;146(3):312-321. doi: 10.5858/arpa.2020-0446-RA.

Abstract

Context.—: Pancreatic cystic lesions are increasingly diagnosed. Among other criteria, they are often distinguished in mucinous versus nonmucinous cysts. Mucinous pancreatic cystic lesions have received increasing attention, especially those known as precursors of pancreatic ductal adenocarcinoma. However, the group of nonmucinous cystic lesions of the pancreas includes numerous entities that may pose a diagnostic challenge. Their accurate diagnosis and classification are crucial for adequate patient management.

Objective.—: To review the spectrum of nonmucinous cystic lesions of the pancreas, taking into consideration their epidemiology and typical clinical context, their characteristic gross morphology and histomorphology, as well as their immunohistochemical and molecular profile.

Data sources.—: Literature was searched and reviewed with MEDLINE via PubMed. Macroscopic and microscopic images were obtained from the archives of the Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Germany.

Conclusions.—: Nonmucinous cysts of the pancreas comprise numerous, mostly rare entities displaying different biological behaviors. The most frequent are serous cystic neoplasms, solid-pseudopapillary neoplasms, cystic neuroendocrine tumors, and pancreatitis-associated pseudocysts. Accurate diagnosis can be achieved if characteristic clinical context, histomorphology, and immunoprofile are taken into account.

MeSH terms

  • Carcinoma, Pancreatic Ductal* / pathology
  • Humans
  • Pancreas / pathology
  • Pancreatic Cyst* / diagnosis
  • Pancreatic Cyst* / pathology
  • Pancreatic Ducts / pathology
  • Pancreatic Neoplasms* / pathology